You just read:

Latest Phase 3 Results Demonstrate Safety and Efficacy Profile of INVOKANA® (canagliflozin) as Add-On Therapy in the Treatment of Type 2 Diabetes in Adults

News provided by

Janssen Research & Development, LLC

24 Sep, 2013, 11:00 BST